00990nam0-2200289 --450 991027915980332120180717115013.0978-88-94003-76-520180716d2015----kmuy0itay5050 baitalatITy 001yyLingue tecniche e retorica dei generi letterari nelle "Eclogae" di G. PontanoCarmela Vera TufanoNapoliPaolo Loffredo2015623 p.24 cmLatinae humanitatis itinera nova1Pontano, Giovanni Gioviano. Eclogae870.900422itaTufano,Carmela Vera747495ITUNINAREICATUNIMARCBK9910279159803321P2B-670-PONTANO 8T.C.V. 2015Bibl. 2018FLFBCP2B-670-PONTANO.8T.C.V. 2015BISBibl. 2018FLFBCFLFBCLingue tecniche e retorica dei generi letterari nelle Eclogae di G. Pontano1493382UNINA05284nam 2201693z- 450 991055738540332120231214132850.0(CKB)5400000000042045(oapen)https://directory.doabooks.org/handle/20.500.12854/68583(EXLCZ)99540000000004204520202105d2021 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierAdvances in Multiple Sclerosis Research-Series IBasel, SwitzerlandMDPI - Multidisciplinary Digital Publishing Institute20211 electronic resource (334 p.)3-03943-947-2 3-03943-948-0 Designing immunotherapeutics, drugs, and anti-inflammatory reagents has been at the forefront of autoimmune research, in particular multiple sclerosis, for over 20 years. Delivery methods that are used to modulate effective and long-lasting immune responses have been the major focus. This Special Issue focused on delivery methods to be used for vaccines, immunotherapeutic approaches, drug design, and anti-inflammatories and their outcomes in preclinical studies and clinical trials.Medicinebicsscmultiple sclerosisinflammationoxidativebiomarkersample sizeautoimmune encephalitisplasma exchangeautoimmunityimmunotherapeuticsclinical outcomesmajor depressionbupropionS-adenosylmethioninevitamin D3yogacraniopharyngiomafractionated stereotactic radiation treatmentssphenoid sinusitiscranial nerve-VI palsyautoimmune diseasesimmune thrombocytopenic purpuraalemtuzumabantibodies against GluR3 peptidecognitive impairmentdiagnosisneuropsychological assessmentshort intracortical inhibitionintracortical facilitationfampridinewalking disabilityTSPAN32tetraspaninscellular immunitymemory T cellstDCSneuroimagingpositron emission tomographycerebral blood flowprobioticsStreptococcus thermophilusST285MBP83–99 peptidemannanimmune modulationagonist peptidegut microbiomegut–brain axismetagenomicsdisease-modifying treatmentsMSvaccineimmunomodulationcarriersB cell receptordelivery methodsimmunotherapymonoclonal antibodiesT cell receptortolerancediagnostic markersimmunoglobulinskappafree light chainsantigen-specific immunotherapiestolerogenic vaccinestolerance inductioncentral nervous systemmyelin peptidesmyelin basic proteiproteolipid proteinmyelin oligodendrocyte glycoproteinnanotechnologydrug delivery nanosystemslipidspolymersvaccinesnanoparticlesantigen-specific immunotherapyexperimental autoimmune encephalomyelitisneurodegenerationchloroquineEAEdendritic cellsmicrogliaastrocytesoligodendrocytesconformational analysispeptidesaltered peptide ligandsNMR spectroscopyNOE-constraintsmolecular dynamictrimolecular complexMultiple Sclerosisearly-onsetadult-onsetHuman Leucocyte Antigensimmunogeneticsclinical phenotypeclinical outcometherapeuticsantibody detectionELISAmultivalencyN-glucosylated peptide epitopespeptideconjugationMOG35-55Graphite/SiO2 electrodevoltammetryHPLCMS drugsMedicineMatsoukas Johnedt1309053Apostolopoulos VassoedtMatsoukas JohnothApostolopoulos VassoothBOOK9910557385403321Advances in Multiple Sclerosis Research-Series I3029272UNINA